An integrated analysis of SOCS1 down-regulation in HBV infection-related hepatocellular carcinoma

Journal of Viral Hepatitis

Volumn 21, Issue 4, 2014, Pages 264-271

  Zhang, X ^a   Wang, J ^a   Cheng, J ^a   Ding, S ^a   Li, M ^a   Sun, S ^b   Zhang, L ^c   Liu, S ^d   Chen, X ^a   Zhuang, H ^a   Lu, F ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c Henan Tumor Hospital   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

hepatitis B virus; hepatocellular carcinoma; methylation; p53; suppressor of cytokine signalling 1

Indexed keywords

MESSENGER RNA; PROTEIN P21; PROTEIN P53; SUPPRESSOR OF CYTOKINE SIGNALING 1; CYTOKINE INDUCIBLE SH2-CONTAINING PROTEIN; LUCIFERASE; NUCLEAR PROTEIN; SOCS1 PROTEIN, HUMAN; SOCS7 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CHROMOSOME ABERRATION; DOWN REGULATION; EPIGENETICS; FEMALE; GENE DELETION; GENE DOSAGE; GENE EXPRESSION; GENE FREQUENCY; GENE LOSS; GENETIC ASSOCIATION; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; METHYLATION; MIDDLE AGED; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TUMOR VOLUME; WESTERN BLOTTING; BIOSYNTHESIS; COMPLICATION; DNA METHYLATION; GENE EXPRESSION PROFILING; GENETIC EPIGENESIS; GENETICS; LIVER TUMOR; PATHOLOGY; REPORTER GENE;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; GENE DELETION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENES, REPORTER; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; LUCIFERASES; NUCLEAR PROTEINS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84895799078     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12137     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, Pisani P,. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94 (2): 153-156.
2. He J, Gu D, Wu X, et al,. Major causes of death among men and women in China. N Engl J Med 2005; 353 (11): 1124-1134.
3. Yeo W, Mo FK, Chan SL, et al,. Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy. Hepatology 2007; 45 (6): 1382-1389.
4. Sharma S, Kelly TK, Jones PA,. Epigenetics in cancer. Carcinogenesis 2010; 31 (1): 27-36.
5. Baylin SB, Ohm JE,. Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006; 6 (2): 107-116.
6. Feinberg AP, Ohlsson R, Henikoff S,. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006; 7 (1): 21-33.
7. Jones PA, Baylin SB,. The epigenomics of cancer. Cell 2007; 128 (4): 683-692.
8. Ram PA, Waxman DJ,. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J Biol Chem 1999; 274 (50): 35553-35561.
9. Yoshikawa H, Matsubara K, Qian GS, et al,. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 2001; 28 (1): 29-35.
10. Calvisi DF, Ladu S, Gorden A, et al,. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest 2007; 117 (9): 2713-2722.
11. Martinez-Chantar ML, Vazquez-Chantada M, Ariz U, et al,. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology 2008; 47 (4): 1191-1199.
12. Jiang S, Yang Z, Li W, et al,. Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis. PLoS ONE 2012; 7 (9): e40363.
13. Calabrese V, Mallette FA, Deschenes-Simard X, et al,. SOCS1 links cytokine signaling to p53 and senescence. Mol Cell 2009; 36 (5): 754-767.
14. Mallette FA, Calabrese V, Ilangumaran S, Ferbeyre G,. SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence. Aging (Albany NY) 2010; 2 (7): 445-452.
15. Niwa Y, Kanda H, Shikauchi Y, et al,. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Oncogene 2005; 24 (42): 6406-6417.
16. Miyoshi H, Fujie H, Moriya K, et al,. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma. J Gastroenterol 2004; 39 (6): 563-569.
17. Um TH, Kim H, Oh BK, et al,. Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis. J Hepatol 2011; 54 (5): 939-947.
18. Nomoto S, Kinoshita T, Kato K, et al,. Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma. Br J Cancer 2007; 97 (9): 1260-1265.
19. Ko E, Kim SJ, Joh JW, Park CK, Park J, Kim DH,. CpG island hypermethylation of SOCS-1 gene is inversely associated with HBV infection in hepatocellular carcinoma. Cancer Lett 2008; 271 (2): 240-250.
20. Nagai H, Kim YS, Konishi N, et al,. Combined hypermethylation and chromosome loss associated with inactivation of SSI-1/SOCS-1/JAB gene in human hepatocellular carcinomas. Cancer Lett 2002; 186 (1): 59-65.
21. Yoshida T, Ogata H, Kamio M, et al,. SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis. J Exp Med 2004; 199 (12): 1701-1707.
22. Lai RH, Wang MJ, Yang SH, Chen JY,. Genomic organization and functional characterization of the promoter for the human suppressor of cytokine signaling 6 gene. Gene 2009; 448 (1): 64-73.
23. Liu XH, Xu SB, Yuan J, et al,. Defective interleukin-4/Stat6 activity correlates with increased constitutive expression of negative regulators SOCS-3, SOCS-7, and CISH in colon cancer cells. J Interferon Cytokine Res 2009; 29 (12): 809-816.
24. Wang Y, Cheng J, Xu C, et al,. Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma. Liver Int 2012; 32 (3): 420-428.
25. de Andres MC, Imagawa K, Hashimoto K, et al,. Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis. Biochem Biophys Res Commun 2011; 407 (1): 54-59.
26. Xie Q, Chen X, Lu F, et al,. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma. Cancer 2011; 117 (9): 2713-2722.
27. Li L, Wu J, Pu D, et al,. Factors associated with the age of natural menopause and menopausal symptoms in Chinese women. Maturitas 2012; 73 (4): 354-360.
28. Rahman SA, Zainudin SR, Mun VL,. Assessment of menopausal symptoms using modified Menopause Rating Scale (MRS) among middle age women in Kuching, Sarawak, Malaysia. Asia Pac Fam Med 2010; 9 (1): 5.
29. Kato I, Toniolo P, Akhmedkhanov A, Koenig KL, Shore R, Zeleniuch-Jacquotte A,. Prospective study of factors influencing the onset of natural menopause. J Clin Epidemiol 1998; 51 (12): 1271-1276.
30. Chu PY, Yeh CM, Hsu NC, Chang YS, Chang JG, Yeh KT,. Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma. Swiss Med Wkly 2010; 140: w13065.
31. Leu YW, Yan PS, Fan M, et al,. Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer. Cancer Res 2004; 64 (22): 8184-8192.
32. Xu H, Wei Y, Zhang Y, et al,. Oestrogen attenuates tumour progression in hepatocellular carcinoma. J Pathol 2012; 228 (2): 216-229.
33. Gao SM, Chen CQ, Wang LY, et al,. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms. Exp Hematol 2013; 41 (3): 261-270.
34. Su C, Hou Z, Zhang C, Tian Z, Zhang J,. Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells. Virol J 2011; 8: 354.
35. Li D, Cao Y, He L, Wang NJ, Gu JR,. Aberrations of p53 gene in human hepatocellular carcinoma from China. Carcinogenesis 1993; 14 (2): 169-173.
36. Liu J, Ma Q, Zhang M, et al,. Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis. Eur J Cancer 2012; 48 (15): 2328-2338.